Radiance to begin major restenosis trial in US
This article was originally published in Clinica
Executive Summary
Radiance Medical Systems, an Irvine, California-based developer of radiation delivering catheters, is to begin a major US trial of its RDX system on patients with in-stent restenosis of coronary arteries. The FDA has granted the company an investigational device exemption conditional upon it providing additional technical information.